Omlyclo

Omalizumab-igec · CELLTRION USA, Inc.
PRESCRIPTION ONLY (USA)

Omlyclo ingredients

Active ingredientStrength
Omalizumab150 mg/mL, 300 mg/2mL, 75 mg/.5mL

What Omlyclo is used for

Omlyclo is a specialist medicine (anti-ige). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Omlyclo
Generic name
Omalizumab-igec
Made by
CELLTRION USA, Inc.
Forms
Injection
Given
Subcutaneous
Drug class
Anti-IgE
FDA approval
Biologic licence (BLA) BLA761399
On the US market since
2026

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Omlyclo?

Omlyclo (Omalizumab-igec) is a specialist medicine made by CELLTRION USA, Inc., approved by the US FDA.

What are the ingredients of Omlyclo?

Omlyclo contains Omalizumab (150 mg/mL, 300 mg/2mL, 75 mg/.5mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.